Concepedia

Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign

Eline Meyers, Liselore De Rop, Ellen Deschepper, Els Duysburgh, Tine De Burghgraeve, Pauline Van Ngoc, Marina Digregorio, Simon Delogne, Anja Coen, Nele De Clercq,

European Journal of General Practice · 2022 · 12 citations · 16 references

Open access

Abstract

This study was retrospectively registered on ClinicalTrials.gov (NCT04738695).

References

16

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.1K citations · Full text

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh, Robert W. Frenck, Ann R. Falsey et al. · New England Journal of Medicine · 2020 · 2.7K citations · Full text

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin et al. · Nature · 2020 · 1.6K citations · Full text

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Dami A. Collier, Isabella A.T.M. Ferreira, Prasanti Kotagiri et al. · Nature · 2021 · 789 citations · Full text

Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination

Lisa Müller, Marcel Andrée, Wiebke Moskorz et al. · Clinical Infectious Diseases · 2021 · 510 citations · Full text